Johan Hansson

Johan Hansson

Karolinska Institute - Stockholm / Sweden
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1550143
Karolinska Institutet
person_outline Johan Hansson's MOST POPULAR ARTICLES
1-) Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma New England Journal of Medicine 371 (20), 1877-1888, 2014
2-) Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial The Lancet 386 (9992), 444-451, 2015
3-) Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study Annals of Oncology 28 (7), 1631-1639, 2017
4-) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types Nature genetics 41 (2), 221-227, 2009
5-) Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling Journal of Biological Chemistry 278 (11), 9100-9106, 2003